{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1470813, "items": [{"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T07:20:36Z", "timestamp": 1575184836153}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2013, 4, 15]]}, "DOI": "10.1158/1078-0432.ccr-12-3518", "type": "journal-article", "created": {"date-parts": [[2013, 2, 20]], "date-time": "2013-02-20T04:15:06Z", "timestamp": 1361333706000}, "page": "2265-2272", "source": "Crossref", "is-referenced-by-count": 64, "title": ["Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer"], "prefix": "10.1158", "volume": "19", "author": [{"given": "A.", "family": "Amatu", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Sartore-Bianchi", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Moutinho", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Belotti", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Bencardino", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Chirico", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Cassingena", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Rusconi", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Esposito", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Nichelatti", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Esteller", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Siena", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2013, 2, 19]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-12-3518", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:59:33Z", "timestamp": 1482469173000}, "score": 86.18271, "issued": {"date-parts": [[2013, 2, 19]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 4, 15]]}, "published-print": {"date-parts": [[2013, 4, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-12-3518", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T00:04:27Z", "timestamp": 1576800267694}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "3_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2015, 1, 20]]}, "abstract": "<jats:p> 583 </jats:p><jats:p> Background: O(6)-methylguanine-DNA-methyltransferase (MGMT) is a DNA repair protein. About 40% of mCRC display MGMT deficiency due to promoter hypermethylation, leading to susceptibility to treatment with cytotoxic alkylating agents. We previously reported that objective clinical response to dacarbazine is confined to tumors harboring MGMT promoter hypermethylation (Amatu et al. Clin Cancer Res 2013). Based on these findings, we conducted a phase II study with TMZ in MGMT-deficient mCRCs after failure of standard therapies (EudraCT 2012-003338-17). Methods: We screened mCRC patients for MGMT promoter hypermethylation on archival FFPE specimens by methylation-specific PCR (MSP). All eligible patients underwent tumor biopsy prior to start of treatment. Patients received TMZ 200 mg/m<jats:sup>2 </jats:sup>po qd days 1-5 q28 until progression or intolerable toxicity. We used a Fleming single-stage design to determine whether PFS rate at 12 week would be \u226535% (H<jats:sub>0</jats:sub>\u226415%, type I error=0.059 (1-sided) and power=0.849). Secondary endpoints included response rate (RR), disease control rate (DCR), overall survival (OS), and association of clinical outcomes with quantitative MGMT evaluation in serum and fresh tissue. Results: 150 patients were screened: 54 (36%) presented MGMT promoter hypermethylation and 29 were eligible and enrolled from December 2012 to May 2014 (M 69%, median age 60y [38-77], mean number of previous treatment lines 5.6). A median of 2 cycles of TMZ were administered (range 1-5). Primary endpoint was not achieved, since PFS rate at 12 weeks was 10.3% (90% CI: 2.9-24.6). DCR was 48.3% (90% CI: 32.0-64.8), median OS 6.2 months (95% CI: 3.7-7.6), and median PFS 2.6 months (95% CI: 1.4-2.7). G3/4 toxicities occurring in \u226510% of patients included: thrombocytopenia (10.3/13.8%), neutropenia (0/10.3%) and increased bilirubin (11.1/0%). Exploratory MGMT quantitative analysis is in progress. Conclusions: In mCRC patients treated with TMZ, selection according to MGMT promoter hypermethylation by MSP did not provide meaningful PFS rate at 12 weeks. Biomarkers analyses on serum and fresh tumor biopsy are ongoing to identify the subgroup of mCRCs benefiting from treatment. Clinical trial information: 2012-003338-17. </jats:p>", "DOI": "10.1200/jco.2015.33.3_suppl.583", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T11:02:52Z", "timestamp": 1487934172000}, "page": "583-583", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Phase II study of temozolomide (TMZ) in metastatic colorectal cancer (mCRC) patients molecularly selected by MGMT promoter hypermethylation."], "prefix": "10.1200", "volume": "33", "author": [{"given": "Alessio", "family": "Amatu", "sequence": "first", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca\u2019 Granda, Milan, Italy"}]}, {"given": "Katia", "family": "Bencardino", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca\u2019 Granda, Milan, Italy"}]}, {"given": "Ludovic", "family": "Barault", "sequence": "additional", "affiliation": [{"name": "Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy"}]}, {"given": "Andrea", "family": "Cassingena", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}, {"given": "Erica", "family": "Bonazzina", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}, {"given": "Silvia", "family": "Ghezzi", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca\u2019 Granda, Milan, Italy"}]}, {"given": "Catia", "family": "Moutinho", "sequence": "additional", "affiliation": [{"name": "Institut d\u2019Investigaci\u00f3n Biomedica de Bellvitge, Barcelona, Spain"}]}, {"given": "Federica", "family": "Tosi", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}, {"given": "Riccardo", "family": "Ricotta", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}, {"given": "Elena", "family": "Magni", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}, {"given": "Rosalinda", "family": "Gatto", "sequence": "additional", "affiliation": [{"name": "CLIOSS, Milano, Italy"}]}, {"given": "Giovanna", "family": "Marrapese", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}, {"given": "Manel", "family": "Esteller", "sequence": "additional", "affiliation": [{"name": "Institut d\u2019Investigaci\u00f3n Biomedica de Bellvitge, Barcelona, Spain"}]}, {"given": "Alberto", "family": "Bardelli", "sequence": "additional", "affiliation": [{"name": "Istituto di Candiolo, Fondazione del Piemonte per l\u2019Oncologia-IRCCS, Candiolo, Italy"}]}, {"given": "Federica", "family": "Di Nicolantonio", "sequence": "additional", "affiliation": [{"name": "University of Turin, Candiolo, Italy"}]}, {"given": "Andrea", "family": "Sartore-Bianchi", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca\u2019 Granda, Milan, Italy"}]}, {"given": "Salvatore", "family": "Siena", "sequence": "additional", "affiliation": [{"name": "Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.3_suppl.583", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:10:54Z", "timestamp": 1574889054000}, "score": 41.682644, "issued": {"date-parts": [[2015, 1, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 1, 20]]}, "issue": "3_suppl"}, "alternative-id": ["10.1200/jco.2015.33.3_suppl.583"], "URL": "http://dx.doi.org/10.1200/jco.2015.33.3_suppl.583", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:52:31Z", "timestamp": 1574531551421}, "reference-count": 33, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 8, 2]], "date-time": "2011-08-02T00:00:00Z", "timestamp": 1312243200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2011, 9]]}, "DOI": "10.1038/bjc.2011.285", "type": "journal-article", "created": {"date-parts": [[2011, 8, 2]], "date-time": "2011-08-02T20:11:00Z", "timestamp": 1312315860000}, "page": "773-777", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours"], "prefix": "10.1038", "volume": "105", "author": [{"given": "H A", "family": "Tawbi", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Villaruz", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Tarhini", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Moschos", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Sulecki", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Viverette", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Shipe-Spotloe", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Radkowski", "sequence": "additional", "affiliation": []}, {"given": "J M", "family": "Kirkwood", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 8, 2]]}, "reference": [{"issue": "23", "key": "BFbjc2011285_CR1", "first-page": "6423", "volume": "52", "author": "TC Ayi", "year": "1992", "unstructured": "Ayi TC, Loh KC, Ali RB, Li BF (1992) Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance. Cancer Res 52 (23): 6423\u20136430", "journal-title": "Cancer Res"}, {"issue": "3", "key": "BFbjc2011285_CR2", "first-page": "193", "volume": "181", "author": "A Barth", "year": "1995", "unstructured": "Barth A, Wanek LA, Morton DL (1995) Prognostic factors in 1521 melanoma patients with distant metastases. J Am Coll Surg 181 (3): 193\u2013201", "journal-title": "J Am Coll Surg"}, {"issue": "3", "key": "BFbjc2011285_CR3", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1007/s00280-007-0442-7", "volume": "60", "author": "ED Batts", "year": "2007", "unstructured": "Batts ED, Maisel C, Kane D, Liu L, Fu P, O'Brien T, Remick S, Bahlis N, Gerson SL (2007) O6-benzylguanine and BCNU in multiple myeloma: a phase II trial. Cancer Chemother Pharmacol 60 (3): 415\u2013421", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "19", "key": "BFbjc2011285_CR4", "first-page": "4363", "volume": "58", "author": "CS Brock", "year": "1998", "unstructured": "Brock CS, Newlands ES, Wedge SR, Bower M, Evans H, Colquhoun I, Roddie M, Glaser M, Brampton MH, Rustin GJ (1998) Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res 58 (19): 4363\u20134367", "journal-title": "Cancer Res"}, {"issue": "9", "key": "BFbjc2011285_CR5", "doi-asserted-by": "publisher", "first-page": "809", "DOI": "10.1056/NEJMoa1002011", "volume": "363", "author": "KT Flaherty", "year": "2010", "unstructured": "Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363 (9): 809\u2013819", "journal-title": "N Engl J Med"}, {"issue": "11", "key": "BFbjc2011285_CR6", "doi-asserted-by": "publisher", "first-page": "3570", "DOI": "10.1200/JCO.1998.16.11.3570", "volume": "16", "author": "HS Friedman", "year": "1998", "unstructured": "Friedman HS, Kokkinakis DM, Pluda J, Friedman AH, Cokgor I, Haglund MM, Ashley DM, Rich J, Dolan ME, Pegg AE, Moschel RC, McLendon RE, Kerby T, Herndon JE, Bigner DD, Schold Jr SC (1998) Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol 16 (11): 3570\u20133575", "journal-title": "J Clin Oncol"}, {"issue": "21", "key": "BFbjc2011285_CR7", "doi-asserted-by": "publisher", "first-page": "7861", "DOI": "10.1158/1078-0432.CCR-05-0060", "volume": "11", "author": "TF Gajewski", "year": "2005", "unstructured": "Gajewski TF, Sosman J, Gerson SL, Liu L, Dolan E, Lin S, Vokes EE (2005) Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma. Clin Cancer Res 11 (21): 7861\u20137865", "journal-title": "Clin Cancer Res"}, {"issue": "4", "key": "BFbjc2011285_CR8", "doi-asserted-by": "publisher", "first-page": "296", "DOI": "10.1038/nrc1319", "volume": "4", "author": "SL Gerson", "year": "2004", "unstructured": "Gerson SL (2004) MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4 (4): 296\u2013307", "journal-title": "Nat Rev Cancer"}, {"issue": "6", "key": "BFbjc2011285_CR9", "doi-asserted-by": "publisher", "first-page": "820", "DOI": "10.1038/sj.bjc.6605796", "volume": "103", "author": "JC Hassel", "year": "2010", "unstructured": "Hassel JC, Sucker A, Edler L, Kurzen H, Moll I, Stresemann C, Spieth K, Mauch C, Rass K, Dummer R, Schadendorf D (2010) MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br J Cancer 103 (6): 820\u2013826", "journal-title": "Br J Cancer"}, {"issue": "10", "key": "BFbjc2011285_CR10", "doi-asserted-by": "publisher", "first-page": "997", "DOI": "10.1056/NEJMoa043331", "volume": "352", "author": "ME Hegi", "year": "2005", "unstructured": "Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 (10): 997\u20131003", "journal-title": "N Engl J Med"}, {"issue": "8", "key": "BFbjc2011285_CR11", "doi-asserted-by": "publisher", "first-page": "711", "DOI": "10.1056/NEJMoa1003466", "volume": "363", "author": "FS Hodi", "year": "2010", "unstructured": "Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebb\u00e9 C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363 (8): 711\u2013723", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "BFbjc2011285_CR12", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.3322/caac.20006", "volume": "59", "author": "A Jemal", "year": "2009", "unstructured": "Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59 (4): 225\u2013249", "journal-title": "CA Cancer J Clin"}, {"issue": "8", "key": "BFbjc2011285_CR13", "doi-asserted-by": "publisher", "first-page": "1245", "DOI": "10.1038/sj.bjc.6605016", "volume": "100", "author": "RF Kefford", "year": "2009", "unstructured": "Kefford RF, Thomas NP, Corrie PG, Palmer C, Abdi E, Kotasek D, Beith J, Ranson M, Mortimer P, Watson AJ, Margison GP, Middleton MR (2009) A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma. Br J Cancer 100 (8): 1245\u20131249", "journal-title": "Br J Cancer"}, {"issue": "2", "key": "BFbjc2011285_CR14", "doi-asserted-by": "publisher", "first-page": "328", "DOI": "10.1158/1078-0432.CCR-05-2543", "volume": "12", "author": "L Liu", "year": "2006", "unstructured": "Liu L, Gerson SL (2006) Targeted modulation of MGMT: clinical implications. Clin Cancer Res 12 (2): 328\u2013331", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "BFbjc2011285_CR15", "doi-asserted-by": "publisher", "first-page": "158", "DOI": "10.1200/JCO.2000.18.1.158", "volume": "18", "author": "MR Middleton", "year": "2000", "unstructured": "Middleton MR, Grob JJ, Aaronson N, Fierlbeck G, Tilgen W, Seiter S, Gore M, Aamdal S, Cebon J, Coates A, Dreno B, Henz M, Schadendorf D, Kapp A, Weiss J, Fraass U, Statkevich P, Muller M, Thatcher N (2000a) Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 18 (1): 158\u2013166", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "BFbjc2011285_CR16", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1007/PL00006737", "volume": "45", "author": "MR Middleton", "year": "2000", "unstructured": "Middleton MR, Kelly J, Goodger S, Thatcher N, Margison GP (2000b) Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenografts. Cancer Chemother Pharmacol 45 (1): 15\u201320", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "10", "key": "BFbjc2011285_CR17", "doi-asserted-by": "publisher", "first-page": "1476", "DOI": "10.1016/j.ejca.2011.04.030", "volume": "47", "author": "PM Patel", "year": "2011", "unstructured": "Patel PM, Suciu S, Mortier L, Kruit WH, Robert C, Schadendorf D, Trefzer U, Punt CJ, Dummer R, Davidson N, Becker J, Conry R, Thompson JA, Hwu WJ, Engelen K, Agarwala SS, Keilholz U, Eggermont AM, Spatz A, On behalf of the EORTC Melanoma Group (2011) Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). Eur J Cancer 47 (10): 1476\u20131483", "journal-title": "Eur J Cancer"}, {"key": "BFbjc2011285_CR18", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/S0079-6603(08)60879-X", "volume": "51", "author": "AE Pegg", "year": "1995", "unstructured": "Pegg AE, Dolan ME, Moschel RC (1995) Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51: 167\u2013223", "journal-title": "Prog Nucleic Acid Res Mol Biol"}, {"issue": "2\u20133", "key": "BFbjc2011285_CR19", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/S1383-5742(00)00017-X", "volume": "462", "author": "AE Pegg", "year": "2000", "unstructured": "Pegg AE (2000) Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 462 (2\u20133): 83\u2013100", "journal-title": "Mutat Res"}, {"issue": "28", "key": "BFbjc2011285_CR20", "doi-asserted-by": "publisher", "first-page": "7178", "DOI": "10.1200/JCO.2005.06.502", "volume": "23", "author": "JA Quinn", "year": "2005", "unstructured": "Quinn JA, Desjardins A, Weingart J, Brem H, Dolan ME, Delaney SM, Vredenburgh J, Rich J, Friedman AH, Reardon DA, Sampson JH, Pegg AE, Moschel RC, Birch R, McLendon RE, Provenzale JM, Gururangan S, Dancey JE, Maxwell J, Tourt-Uhlig S, Herndon II JE, Bigner DD, Friedman HS (2005) Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol 23 (28): 7178\u20137187", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "BFbjc2011285_CR21", "doi-asserted-by": "publisher", "first-page": "2277", "DOI": "10.1200/JCO.2002.09.084", "volume": "20", "author": "JA Quinn", "year": "2002", "unstructured": "Quinn JA, Pluda J, Dolan ME, Delaney S, Kaplan R, Rich JN, Friedman AH, Reardon DA, Sampson JH, Colvin OM, Haglund MM, Pegg AE, Moschel RC, McLendon RE, Provenzale JM, Gururangan S, Tourt-Uhlig S, Herndon II JE, Bigner DD, Friedman HS (2002) Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. J Clin Oncol 20 (9): 2277\u20132283", "journal-title": "J Clin Oncol"}, {"issue": "18", "key": "BFbjc2011285_CR22", "doi-asserted-by": "publisher", "first-page": "2540", "DOI": "10.1200/JCO.2007.10.8217", "volume": "25", "author": "M Ranson", "year": "2007", "unstructured": "Ranson M, Hersey P, Thompson D, Beith J, McArthur GA, Haydon A, Davis ID, Kefford RF, Mortimer P, Harris PA, Baka S, Seebaran A, Sabharwal A, Watson AJ, Margison GP, Middleton MR (2007) Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma. J Clin Oncol 25 (18): 2540\u20132545", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "BFbjc2011285_CR23", "doi-asserted-by": "publisher", "first-page": "1577", "DOI": "10.1158/1078-0432.CCR-05-2198", "volume": "12", "author": "M Ranson", "year": "2006", "unstructured": "Ranson M, Middleton MR, Bridgewater J, Lee SM, Dawson M, Jowle D, Halbert G, Waller S, McGrath H, Gumbrell L, McElhinney RS, Donnelly D, McMurry TB, Margison GP (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res 12 (5): 1577\u20131584", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "BFbjc2011285_CR24", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1001/archdermatol.2009.379", "volume": "146", "author": "DS Rigel", "year": "2010", "unstructured": "Rigel DS (2010) Trends in dermatology: melanoma incidence. Arch Dermatol 146 (3): 318", "journal-title": "Arch Dermatol"}, {"issue": "5", "key": "BFbjc2011285_CR25", "doi-asserted-by": "publisher", "first-page": "634", "DOI": "10.1007/s00280-006-0210-0", "volume": "58", "author": "CW Ryan", "year": "2006", "unstructured": "Ryan CW, Dolan ME, Brockstein BB, McLendon R, Delaney SM, Samuels BL, Agamah ES, Vokes EE (2006) A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma. Cancer Chemother Pharmacol 58 (5): 634\u2013639", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "8", "key": "BFbjc2011285_CR26", "first-page": "3025", "volume": "6", "author": "RL Schilsky", "year": "2000", "unstructured": "Schilsky RL, Dolan ME, Bertucci D, Ewesuedo RB, Vogelzang NJ, Mani S, Wilson LR, Ratain MJ (2000) Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer. Clin Cancer Res 6 (8): 3025\u20133031", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "BFbjc2011285_CR27", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1215/S115285170300019X", "volume": "6", "author": "SC Schold Jr", "year": "2004", "unstructured": "Schold Jr SC, Kokkinakis DM, Chang SM, Berger MS, Hess KR, Schiff D, Robins HI, Mehta MP, Fink KL, Davis RL, Prados MD (2004) O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas. Neuro Oncol 6 (1): 28\u201332", "journal-title": "Neuro Oncol"}, {"issue": "7", "key": "BFbjc2011285_CR28", "first-page": "1129", "volume": "2", "author": "DC Smith", "year": "1996", "unstructured": "Smith DC, Gerson SL, Liu L, Donnelly S, Day R, Trump DL, Kirkwood JM (1996) Carmustine and streptozotocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase. Clin Cancer Res 2 (7): 1129\u20131134", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "BFbjc2011285_CR29", "first-page": "2402", "volume": "59", "author": "TP Spiro", "year": "1999", "unstructured": "Spiro TP, Gerson SL, Liu L, Majka S, Haaga J, Hoppel CL, Ingalls ST, Pluda JM, Willson JK (1999) O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res 59 (10): 2402\u20132410", "journal-title": "Cancer Res"}, {"issue": "8", "key": "BFbjc2011285_CR30", "first-page": "2309", "volume": "7", "author": "TP Spiro", "year": "2001", "unstructured": "Spiro TP, Liu L, Majka S, Haaga J, Willson JK, Gerson SL (2001) Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase. Clin Cancer Res 7 (8): 2309\u20132317", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "BFbjc2011285_CR31", "doi-asserted-by": "publisher", "first-page": "532", "DOI": "10.1053/j.seminoncol.2007.09.008", "volume": "34", "author": "HA Tawbi", "year": "2007", "unstructured": "Tawbi HA, Kirkwood JM (2007) Management of metastatic melanoma. Semin Oncol 34 (6): 532\u2013545", "journal-title": "Semin Oncol"}, {"issue": "30", "key": "BFbjc2011285_CR32", "doi-asserted-by": "publisher", "first-page": "7646", "DOI": "10.1200/JCO.2005.02.0024", "volume": "23", "author": "KE Warren", "year": "2005", "unstructured": "Warren KE, Aikin AA, Libucha M, Widemann BC, Fox E, Packer RJ, Balis FM (2005) Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors. J Clin Oncol 23 (30): 7646\u20137653", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "BFbjc2011285_CR33", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1200/JCO.2006.06.6290", "volume": "25", "author": "J Weingart", "year": "2007", "unstructured": "Weingart J, Grossman SA, Carson KA, Fisher JD, Delaney SM, Rosenblum ML, Olivi A, Judy K, Tatter SB, Dolan ME (2007) Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol 25 (4): 399\u2013404", "journal-title": "J Clin Oncol"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc2011285.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc2011285", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc2011285.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 13]], "date-time": "2019-04-13T20:07:28Z", "timestamp": 1555186048000}, "score": 34.797577, "issued": {"date-parts": [[2011, 8, 2]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2011, 9]]}, "issue": "6"}, "alternative-id": ["BFbjc2011285"], "URL": "http://dx.doi.org/10.1038/bjc.2011.285", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:34:13Z", "timestamp": 1574148853693}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 9, 1]], "date-time": "2004-09-01T00:00:00Z", "timestamp": 1093996800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2004, 9]]}, "DOI": "10.1016/s1359-6349(04)80644-x", "type": "journal-article", "created": {"date-parts": [[2004, 11, 18]], "date-time": "2004-11-18T06:37:36Z", "timestamp": 1100759856000}, "page": "192", "source": "Crossref", "is-referenced-by-count": 0, "title": ["636 Promoter hypermethylation of the DNA repair gene mgmt is more frequent in secondary glioblastomas and is independent from other prognostic factors"], "prefix": "10.1016", "volume": "2", "author": [{"given": "M.", "family": "Eoli", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "Bissola", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Menghi", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Pollo", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Silvani", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Broggi", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Boiardi", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Finocchiaro", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S135963490480644X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S135963490480644X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 2]], "date-time": "2019-02-02T00:20:27Z", "timestamp": 1549066827000}, "score": 33.963013, "issued": {"date-parts": [[2004, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 9]]}, "issue": "8"}, "alternative-id": ["S135963490480644X"], "URL": "http://dx.doi.org/10.1016/s1359-6349(04)80644-x", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:59:15Z", "timestamp": 1575305955288}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 5, 1]], "date-time": "2005-05-01T00:00:00Z", "timestamp": 1114905600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Colorectal Cancer"], "published-print": {"date-parts": [[2005, 5]]}, "DOI": "10.3816/ccc.2005.n.016", "type": "journal-article", "created": {"date-parts": [[2008, 9, 11]], "date-time": "2008-09-11T01:06:10Z", "timestamp": 1221095170000}, "page": "50-56", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer"], "prefix": "10.3816", "volume": "5", "author": [{"given": "Thomas", "family": "Cartwright", "sequence": "first", "affiliation": []}, {"given": "Timothy", "family": "Lopez", "sequence": "additional", "affiliation": []}, {"given": "Svetislava J.", "family": "Vukelja", "sequence": "additional", "affiliation": []}, {"given": "Carlos", "family": "Encarnacion", "sequence": "additional", "affiliation": []}, {"given": "Kristi A.", "family": "Boehm", "sequence": "additional", "affiliation": []}, {"given": "Lina", "family": "Asmar", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Colorectal Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1533002811701657?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1533002811701657?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 13]], "date-time": "2019-05-13T22:57:39Z", "timestamp": 1557788259000}, "score": 33.73949, "issued": {"date-parts": [[2005, 5]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2005, 5]]}, "issue": "1"}, "alternative-id": ["S1533002811701657"], "URL": "http://dx.doi.org/10.3816/ccc.2005.n.016", "ISSN": ["1533-0028"], "issn-type": [{"value": "1533-0028", "type": "print"}], "subject": ["Gastroenterology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T11:55:21Z", "timestamp": 1575287721925}, "reference-count": 39, "publisher": "Informa UK Limited", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Epigenetics"], "published-print": {"date-parts": [[2013, 12]]}, "DOI": "10.4161/epi.26486", "type": "journal-article", "created": {"date-parts": [[2013, 10, 9]], "date-time": "2013-10-09T20:55:30Z", "timestamp": 1381352130000}, "page": "1254-1260", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer"], "prefix": "10.1080", "volume": "8", "author": [{"given": "Scott J", "family": "Diede", "sequence": "first", "affiliation": []}, {"given": "Zizhen", "family": "Yao", "sequence": "additional", "affiliation": []}, {"given": "C Chip", "family": "Keyes", "sequence": "additional", "affiliation": []}, {"given": "Ashlee E", "family": "Tyler", "sequence": "additional", "affiliation": []}, {"given": "Joyoti", "family": "Dey", "sequence": "additional", "affiliation": []}, {"given": "Christopher S", "family": "Hackett", "sequence": "additional", "affiliation": []}, {"given": "Katrina", "family": "Elsaesser", "sequence": "additional", "affiliation": []}, {"given": "Christopher J", "family": "Kemp", "sequence": "additional", "affiliation": []}, {"given": "Paul E", "family": "Neiman", "sequence": "additional", "affiliation": []}, {"given": "William A", "family": "Weiss", "sequence": "additional", "affiliation": []}, {"given": "James M", "family": "Olson", "sequence": "additional", "affiliation": []}, {"given": "Stephen J", "family": "Tapscott", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 10, 27]]}, "reference": [{"key": "R1", "DOI": "10.1016/j.cell.2011.02.013", "doi-asserted-by": "publisher"}, {"key": "R2", "DOI": "10.1126/science.1235122", "doi-asserted-by": "publisher"}, {"key": "R3", "DOI": "10.1038/nrg3270", "doi-asserted-by": "publisher"}, {"key": "R4", "DOI": "10.1038/nrc3130", "doi-asserted-by": "publisher"}, {"key": "R5", "DOI": "10.1200/JCO.2010.30.8304", "doi-asserted-by": "publisher"}, {"key": "R6", "DOI": "10.1073/pnas.0907606106", "doi-asserted-by": "publisher"}, {"key": "R7", "DOI": "10.1158/0008-5472.CAN-04-1813", "doi-asserted-by": "publisher"}, {"key": "R8", "DOI": "10.4161/epi.19463", "doi-asserted-by": "publisher"}, {"key": "R9", "DOI": "10.1128/MCB.00862-12", "doi-asserted-by": "publisher"}, {"key": "R10", "DOI": "10.1038/nprot.2010.190", "doi-asserted-by": "publisher"}, {"key": "R11", "DOI": "10.1101/gad.1907510", "doi-asserted-by": "publisher"}, {"key": "R12", "DOI": "10.1038/nn1576", "doi-asserted-by": "publisher"}, {"key": "R13", "DOI": "10.1523/JNEUROSCI.3229-04.2004", "doi-asserted-by": "publisher"}, {"key": "R14", "DOI": "10.1523/JNEUROSCI.2285-06.2006", "doi-asserted-by": "publisher"}, {"key": "R15", "DOI": "10.1038/emboj.2009.32", "doi-asserted-by": "publisher"}, {"key": "R16", "DOI": "10.1084/jem.167.2.353", "doi-asserted-by": "publisher"}, {"key": "R17", "DOI": "10.1016/S1535-6108(02)00212-X", "doi-asserted-by": "publisher"}, {"key": "R18", "DOI": "10.1158/0008-5472.CAN-10-4026", "doi-asserted-by": "publisher"}, {"key": "R19", "DOI": "10.1158/0008-5472.CAN-08-1419", "doi-asserted-by": "publisher"}, {"key": "R20", "DOI": "10.1186/bcr2121", "doi-asserted-by": "publisher"}, {"key": "R21", "DOI": "10.1186/1471-2164-11-137", "doi-asserted-by": "publisher"}, {"key": "R22", "DOI": "10.1038/sj.bjc.6605711", "doi-asserted-by": "publisher"}, {"key": "R23", "DOI": "10.1038/sj.bjc.6602422", "doi-asserted-by": "publisher"}, {"key": "R24", "DOI": "10.1182/blood-2008-04-152900", "doi-asserted-by": "publisher"}, {"key": "R25", "DOI": "10.1101/gr.147942.112", "doi-asserted-by": "publisher"}, {"key": "R26", "DOI": "10.1073/pnas.87.16.6117", "doi-asserted-by": "publisher"}, {"key": "R27", "DOI": "10.1038/ng.2442", "doi-asserted-by": "publisher"}, {"key": "R28", "DOI": "10.1158/0008-5472.CAN-08-4977", "doi-asserted-by": "publisher"}, {"key": "R29", "DOI": "10.1093/nar/gks1051", "doi-asserted-by": "publisher"}, {"key": "R30", "DOI": "10.1083/jcb.17.2.299", "doi-asserted-by": "publisher"}, {"key": "R31", "DOI": "10.1101/gr.106542.110", "doi-asserted-by": "publisher"}, {"key": "R32", "DOI": "10.1158/0008-5472.CAN-10-0847", "doi-asserted-by": "publisher"}, {"key": "R33", "DOI": "10.1172/JCI43169", "doi-asserted-by": "publisher"}, {"key": "R34", "DOI": "10.1053/j.gastro.2003.11.010", "doi-asserted-by": "publisher"}, {"key": "R35", "DOI": "10.1158/0008-5472.CAN-08-1957", "doi-asserted-by": "publisher"}, {"key": "R36", "DOI": "10.1016/j.ccr.2011.09.012", "doi-asserted-by": "publisher"}, {"key": "R37", "author": "Klein E", "volume": "28", "first-page": "1300", "year": "1968", "journal-title": "Cancer Res"}, {"key": "R38", "DOI": "10.1016/S0140-6736(64)92345-1", "doi-asserted-by": "publisher"}, {"key": "R39", "DOI": "10.1186/1471-2105-10-232", "doi-asserted-by": "publisher"}], "container-title": ["Epigenetics"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/epi.26486", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T20:22:00Z", "timestamp": 1481660520000}, "score": 33.649597, "issued": {"date-parts": [[2013, 12]]}, "references-count": 39, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 27]]}, "published-print": {"date-parts": [[2013, 12]]}, "issue": "12"}, "alternative-id": ["10.4161/epi.26486"], "URL": "http://dx.doi.org/10.4161/epi.26486", "relation": {"cites": []}, "ISSN": ["1559-2294", "1559-2308"], "issn-type": [{"value": "1559-2294", "type": "print"}, {"value": "1559-2308", "type": "electronic"}], "subject": ["Cancer Research", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T17:01:53Z", "timestamp": 1574874113604}, "reference-count": 0, "publisher": "Impact Journals, LLC", "issue": "69", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncotarget"], "published-print": {"date-parts": [[2018, 9, 4]]}, "DOI": "10.18632/oncotarget.26074", "type": "journal-article", "created": {"date-parts": [[2018, 9, 4]], "date-time": "2018-09-04T16:47:40Z", "timestamp": 1536079660000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["CpG island hypermethylation go circular (RNA)"], "prefix": "10.18632", "volume": "9", "author": [{"given": "Mihnea P.", "family": "Dragomir", "sequence": "first", "affiliation": []}, {"given": "George A.", "family": "Calin", "sequence": "additional", "affiliation": []}], "member": "7892", "published-online": {"date-parts": [[2018, 8, 26]]}, "container-title": ["Oncotarget"], "language": "en", "link": [{"URL": "http://www.oncotarget.com/fulltext/26074", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T21:40:43Z", "timestamp": 1542750043000}, "score": 33.517303, "issued": {"date-parts": [[2018, 8, 26]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2018, 9, 4]]}, "issue": "69"}, "alternative-id": ["26074"], "URL": "http://dx.doi.org/10.18632/oncotarget.26074", "ISSN": ["1949-2553"], "issn-type": [{"value": "1949-2553", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T23:17:15Z", "timestamp": 1574378235410}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 7, 1]], "date-time": "2008-07-01T00:00:00Z", "timestamp": 1214870400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2008, 7]]}, "DOI": "10.1016/s1359-6349(08)71520-9", "type": "journal-article", "created": {"date-parts": [[2008, 7, 11]], "date-time": "2008-07-11T11:29:46Z", "timestamp": 1215775786000}, "page": "89", "source": "Crossref", "is-referenced-by-count": 0, "title": ["O6-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation in neoplastic and normal mucosa in patients with colorectal carcinoma(CRC)"], "prefix": "10.1016", "volume": "6", "author": [{"given": "P.", "family": "Stravoravdi", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Paikos", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Voyatzi", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Tragiannidis", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Soufleris", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Pilpilidis", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Tarpangos", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Katsos", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634908715209?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634908715209?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 27]], "date-time": "2018-12-27T08:28:03Z", "timestamp": 1545899283000}, "score": 33.360928, "issued": {"date-parts": [[2008, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 7]]}, "issue": "9"}, "alternative-id": ["S1359634908715209"], "URL": "http://dx.doi.org/10.1016/s1359-6349(08)71520-9", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:43:10Z", "timestamp": 1574516590625}, "reference-count": 43, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 9, 1]], "date-time": "2011-09-01T00:00:00Z", "timestamp": 1314835200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Colorectal Cancer"], "published-print": {"date-parts": [[2011, 9]]}, "DOI": "10.1016/j.clcc.2011.03.018", "type": "journal-article", "created": {"date-parts": [[2011, 6, 8]], "date-time": "2011-06-08T18:22:24Z", "timestamp": 1307557344000}, "page": "210-216", "source": "Crossref", "is-referenced-by-count": 7, "title": ["A Phase II Study of Oxaliplatin, Dose-intense Capecitabine, and High-dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer"], "prefix": "10.1016", "volume": "10", "author": [{"given": "Nan Soon", "family": "Wong", "sequence": "first", "affiliation": []}, {"given": "Nishan H.", "family": "Fernando", "sequence": "additional", "affiliation": []}, {"given": "Johanna C.", "family": "Bendell", "sequence": "additional", "affiliation": []}, {"given": "Michael A.", "family": "Morse", "sequence": "additional", "affiliation": []}, {"given": "Gerard C.", "family": "Blobe", "sequence": "additional", "affiliation": []}, {"given": "Wanda", "family": "Honeycutt", "sequence": "additional", "affiliation": []}, {"given": "Herbert", "family": "Pang", "sequence": "additional", "affiliation": []}, {"given": "Herbert I.", "family": "Hurwitz", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Colorectal Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1533002811000193?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1533002811000193?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 11]], "date-time": "2019-06-11T14:30:35Z", "timestamp": 1560263435000}, "score": 33.27255, "issued": {"date-parts": [[2011, 9]]}, "references-count": 43, "journal-issue": {"published-print": {"date-parts": [[2011, 9]]}, "issue": "3"}, "alternative-id": ["S1533002811000193"], "URL": "http://dx.doi.org/10.1016/j.clcc.2011.03.018", "ISSN": ["1533-0028"], "issn-type": [{"value": "1533-0028", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T20:00:24Z", "timestamp": 1574539224099}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2013, 4, 15]]}, "DOI": "10.1158/1538-7445.am2013-1155", "type": "proceedings-article", "created": {"date-parts": [[2014, 8, 14]], "date-time": "2014-08-14T23:08:53Z", "timestamp": 1408057733000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 1155: Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in colorectal cancer."], "prefix": "10.1158", "author": [{"given": "Linda JW", "family": "Bosch", "sequence": "first", "affiliation": []}, {"given": "Geert", "family": "Trooskens", "sequence": "additional", "affiliation": []}, {"given": "Petur", "family": "Snaebjornsson", "sequence": "additional", "affiliation": []}, {"given": "Josien C.", "family": "Haan", "sequence": "additional", "affiliation": []}, {"given": "Lorraine", "family": "Pelosof", "sequence": "additional", "affiliation": []}, {"given": "Miriam", "family": "Koopman", "sequence": "additional", "affiliation": []}, {"given": "Jolien", "family": "Tol", "sequence": "additional", "affiliation": []}, {"given": "Joost", "family": "Louwagie", "sequence": "additional", "affiliation": []}, {"given": "Luc", "family": "Dehaspe", "sequence": "additional", "affiliation": []}, {"given": "Bauke", "family": "Ylstra", "sequence": "additional", "affiliation": []}, {"given": "Henk", "family": "Verheul", "sequence": "additional", "affiliation": []}, {"given": "Manon", "family": "van Engeland", "sequence": "additional", "affiliation": []}, {"given": "Iris D.", "family": "Nagtegaal", "sequence": "additional", "affiliation": []}, {"given": "James G.", "family": "Herman", "sequence": "additional", "affiliation": []}, {"given": "Cornelis JA", "family": "Punt", "sequence": "additional", "affiliation": []}, {"given": "Wim", "family": "van Criekinge", "sequence": "additional", "affiliation": []}, {"given": "Beatriz", "family": "Carvalho", "sequence": "additional", "affiliation": []}, {"given": "Gerrit A.", "family": "Meijer", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 18]]}, "event": {"name": "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC"}, "container-title": ["Clinical Research"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2013-1155", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T19:54:36Z", "timestamp": 1558209276000}, "score": 33.1289, "issued": {"date-parts": [[2013, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2013-1155"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2013-1155"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:15:58Z", "timestamp": 1574277358803}, "reference-count": 0, "publisher": "BMJ", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "DOI": "10.1136/gut.2007.119750", "type": "journal-article", "created": {"date-parts": [[2007, 3, 6]], "date-time": "2007-03-06T01:03:20Z", "timestamp": 1173143000000}, "page": "1564-1571", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer"], "prefix": "10.1136", "volume": "56", "author": [{"given": "S.", "family": "Ogino", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Kawasaki", "sequence": "additional", "affiliation": []}, {"given": "G. J", "family": "Kirkner", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Suemoto", "sequence": "additional", "affiliation": []}, {"given": "J. A", "family": "Meyerhardt", "sequence": "additional", "affiliation": []}, {"given": "C. S", "family": "Fuchs", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2007, 6, 29]]}, "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.2007.119750", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T12:14:03Z", "timestamp": 1482495243000}, "score": 32.234943, "issued": {"date-parts": [[2007, 6, 29]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2007, 6, 29]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1136/gut.2007.119750", "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:03:16Z", "timestamp": 1574334196326}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Epidemiology Biomarkers & Prevention"], "published-print": {"date-parts": [[2009, 11, 1]]}, "DOI": "10.1158/1055-9965.epi-09-0289", "type": "journal-article", "created": {"date-parts": [[2009, 11, 9]], "date-time": "2009-11-09T05:37:49Z", "timestamp": 1257745069000}, "page": "3086-3096", "source": "Crossref", "is-referenced-by-count": 57, "title": ["Genetic Variants of Methyl Metabolizing Enzymes and Epigenetic Regulators: Associations with Promoter CpG Island Hypermethylation in Colorectal Cancer"], "prefix": "10.1158", "volume": "18", "author": [{"given": "S.", "family": "de Vogel", "sequence": "first", "affiliation": []}, {"given": "K. A.D.", "family": "Wouters", "sequence": "additional", "affiliation": []}, {"given": "R. W.H.", "family": "Gottschalk", "sequence": "additional", "affiliation": []}, {"given": "F. J.", "family": "van Schooten", "sequence": "additional", "affiliation": []}, {"given": "A. F.P.M.", "family": "de Goeij", "sequence": "additional", "affiliation": []}, {"given": "A. P.", "family": "de Bruine", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "Goldbohm", "sequence": "additional", "affiliation": []}, {"given": "P. A.", "family": "van den Brandt", "sequence": "additional", "affiliation": []}, {"given": "M. P.", "family": "Weijenberg", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "van Engeland", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2009, 10, 20]]}, "container-title": ["Cancer Epidemiology Biomarkers & Prevention"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1055-9965.EPI-09-0289", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T01:55:15Z", "timestamp": 1482458115000}, "score": 31.790789, "issued": {"date-parts": [[2009, 10, 20]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 11, 8]]}, "published-print": {"date-parts": [[2009, 11, 1]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1158/1055-9965.epi-09-0289", "ISSN": ["1055-9965", "1538-7755"], "issn-type": [{"value": "1055-9965", "type": "print"}, {"value": "1538-7755", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T17:48:26Z", "timestamp": 1574790506157}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "18", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2016, 9, 15]]}, "DOI": "10.1158/1078-0432.ccr-15-2703", "type": "journal-article", "created": {"date-parts": [[2016, 4, 28]], "date-time": "2016-04-28T16:38:04Z", "timestamp": 1461861484000}, "page": "4612-4622", "source": "Crossref", "is-referenced-by-count": 4, "title": ["WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy"], "prefix": "10.1158", "volume": "22", "author": [{"given": "L. J. W.", "family": "Bosch", "sequence": "first", "affiliation": []}, {"given": "Y.", "family": "Luo", "sequence": "additional", "affiliation": []}, {"given": "V. V.", "family": "Lao", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Snaebjornsson", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Trooskens", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Vlassenbroeck", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Mongera", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Tang", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Welcsh", "sequence": "additional", "affiliation": []}, {"given": "J. G.", "family": "Herman", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Koopman", "sequence": "additional", "affiliation": []}, {"given": "I. D.", "family": "Nagtegaal", "sequence": "additional", "affiliation": []}, {"given": "C. J. A.", "family": "Punt", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "van Criekinge", "sequence": "additional", "affiliation": []}, {"given": "G. A.", "family": "Meijer", "sequence": "additional", "affiliation": []}, {"given": "R. J.", "family": "Monnat", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Carvalho", "sequence": "additional", "affiliation": []}, {"given": "W. M.", "family": "Grady", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 4, 27]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-15-2703", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:27:26Z", "timestamp": 1482463646000}, "score": 31.77003, "issued": {"date-parts": [[2016, 4, 27]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 9, 15]]}, "published-print": {"date-parts": [[2016, 9, 15]]}, "issue": "18"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-15-2703", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:51:09Z", "timestamp": 1574477469759}, "reference-count": 29, "publisher": "Asian Pacific Organization for Cancer Prevention", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Asian Pacific Journal of Cancer Prevention"], "published-print": {"date-parts": [[2012, 1, 31]]}, "DOI": "10.7314/apjcp.2012.13.1.371", "type": "journal-article", "created": {"date-parts": [[2012, 5, 22]], "date-time": "2012-05-22T05:55:56Z", "timestamp": 1337666156000}, "page": "371-376", "source": "Crossref", "is-referenced-by-count": 10, "title": ["5'-CpG Island Promoter Hypermethylation of the CAV-1 Gene in Breast Cancer Patients of Kashmir"], "prefix": "10.7314", "volume": "13", "author": [{"given": "Nidda", "family": "Syeed", "sequence": "first", "affiliation": []}, {"given": "Firdous", "family": "Hussain", "sequence": "additional", "affiliation": []}, {"given": "Syed Akhtar", "family": "Husain", "sequence": "additional", "affiliation": []}, {"given": "Mushtaq A.", "family": "Siddiqi", "sequence": "additional", "affiliation": []}], "member": "4268", "container-title": ["Asian Pacific Journal of Cancer Prevention"], "language": "en", "link": [{"URL": "http://ocean.kisti.re.kr/downfile/crosscheck/apocp/JAKO201212851254541.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T19:02:57Z", "timestamp": 1497985377000}, "score": 31.748951, "issued": {"date-parts": [[2012, 1, 31]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2012, 1, 31]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.7314/apjcp.2012.13.1.371", "ISSN": ["1513-7368"], "issn-type": [{"value": "1513-7368", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:17:25Z", "timestamp": 1574407045195}, "reference-count": 49, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 4, 1]], "date-time": "2010-04-01T00:00:00Z", "timestamp": 1270080000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["DNA Repair"], "published-print": {"date-parts": [[2010, 4]]}, "DOI": "10.1016/j.dnarep.2010.01.002", "type": "journal-article", "created": {"date-parts": [[2010, 1, 22]], "date-time": "2010-01-22T10:28:23Z", "timestamp": 1264156103000}, "page": "421-428", "source": "Crossref", "is-referenced-by-count": 16, "title": ["MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study"], "prefix": "10.1016", "volume": "9", "author": [{"given": "Yet Hua", "family": "Loh", "sequence": "first", "affiliation": []}, {"given": "Panagiota N.", "family": "Mitrou", "sequence": "additional", "affiliation": []}, {"given": "Richard", "family": "Bowman", "sequence": "additional", "affiliation": []}, {"given": "Angela", "family": "Wood", "sequence": "additional", "affiliation": []}, {"given": "Hannah", "family": "Jeffery", "sequence": "additional", "affiliation": []}, {"given": "Robert N.", "family": "Luben", "sequence": "additional", "affiliation": []}, {"given": "Marleen A.H.", "family": "Lentjes", "sequence": "additional", "affiliation": []}, {"given": "Kay-Tee", "family": "Khaw", "sequence": "additional", "affiliation": []}, {"given": "Sheila A.", "family": "Rodwell", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["DNA Repair"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1568786410000030?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1568786410000030?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 25]], "date-time": "2019-05-25T08:58:00Z", "timestamp": 1558774680000}, "score": 31.597513, "issued": {"date-parts": [[2010, 4]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2010, 4]]}, "issue": "4"}, "alternative-id": ["S1568786410000030"], "URL": "http://dx.doi.org/10.1016/j.dnarep.2010.01.002", "ISSN": ["1568-7864"], "issn-type": [{"value": "1568-7864", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T01:01:50Z", "timestamp": 1574470910439}, "reference-count": 47, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Causes Control"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1007/s10552-010-9659-6", "type": "journal-article", "created": {"date-parts": [[2010, 10, 19]], "date-time": "2010-10-19T11:03:06Z", "timestamp": 1287486186000}, "page": "1-12", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet\u2013gene interactions and promoter CpG island hypermethylation in colorectal cancer"], "prefix": "10.1007", "volume": "22", "author": [{"given": "Stefan", "family": "de Vogel", "sequence": "first", "affiliation": []}, {"given": "Kim A. D.", "family": "Wouters", "sequence": "additional", "affiliation": []}, {"given": "Ralph W. H.", "family": "Gottschalk", "sequence": "additional", "affiliation": []}, {"given": "Frederik J.", "family": "van Schooten", "sequence": "additional", "affiliation": []}, {"given": "Anton F. P. M.", "family": "de Goeij", "sequence": "additional", "affiliation": []}, {"given": "Adriaan P.", "family": "de Bru\u00efne", "sequence": "additional", "affiliation": []}, {"given": "R. Alexandra", "family": "Goldbohm", "sequence": "additional", "affiliation": []}, {"given": "Piet A.", "family": "van den Brandt", "sequence": "additional", "affiliation": []}, {"given": "Manon", "family": "van Engeland", "sequence": "additional", "affiliation": []}, {"given": "Matty P.", "family": "Weijenberg", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 10, 20]]}, "reference": [{"key": "9659_CR1", "doi-asserted-by": "crossref", "first-page": "2042", "DOI": "10.1056/NEJMra023075", "volume": "349", "author": "JG Herman", "year": "2003", "unstructured": "Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042\u20132054", "journal-title": "N Engl J Med"}, {"key": "9659_CR2", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1038/ng1834", "volume": "38", "author": "DJ Weisenberger", "year": "2006", "unstructured": "Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787\u2013793", "journal-title": "Nat Genet"}, {"key": "9659_CR3", "doi-asserted-by": "crossref", "first-page": "2703", "DOI": "10.1093/jn/135.11.2703", "volume": "135", "author": "YI Kim", "year": "2005", "unstructured": "Kim YI (2005) Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135:2703\u20132709", "journal-title": "J Nutr"}, {"key": "9659_CR4", "doi-asserted-by": "crossref", "first-page": "2698", "DOI": "10.1093/jn/135.11.2698", "volume": "135", "author": "CM Ulrich", "year": "2005", "unstructured": "Ulrich CM (2005) Nutrigenetics in cancer research\u2013folate metabolism and colorectal cancer. J Nutr 135:2698\u20132702", "journal-title": "J Nutr"}, {"key": "9659_CR5", "first-page": "511", "volume": "13", "author": "YI Kim", "year": "2004", "unstructured": "Kim YI (2004) Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13:511\u2013519", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9659_CR6", "doi-asserted-by": "crossref", "first-page": "838", "DOI": "10.1038/sj.bjc.6602439", "volume": "92", "author": "M Pufulete", "year": "2005", "unstructured": "Pufulete M, Al-Ghnaniem R, Rennie JA et al (2005) Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. Br J Cancer 92:838\u2013842", "journal-title": "Br J Cancer"}, {"key": "9659_CR7", "unstructured": "Linhart HG, Troen A, Bell GW et al. (2009) Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations. Gastroenterology 136: 227\u2013235 e3", "DOI": "10.1053/j.gastro.2008.10.016", "doi-asserted-by": "crossref"}, {"key": "9659_CR8", "doi-asserted-by": "crossref", "first-page": "794", "DOI": "10.1136/gut.2009.183707", "volume": "59", "author": "ES Schernhammer", "year": "2010", "unstructured": "Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S (2010) Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut 59:794\u2013799", "journal-title": "Gut"}, {"key": "9659_CR9", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1136/gut.2004.054718", "volume": "54", "author": "M Pufulete", "year": "2005", "unstructured": "Pufulete M, Al-Ghnaniem R, Khushal A et al (2005) Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 54:648\u2013653", "journal-title": "Gut"}, {"key": "9659_CR10", "first-page": "3133", "volume": "63", "author": "M Engeland van", "year": "2003", "unstructured": "van Engeland M, Weijenberg MP, Roemen GM et al (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63:3133\u20133137", "journal-title": "Cancer Res"}, {"key": "9659_CR11", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1002/ijc.22342", "volume": "120", "author": "ML Slattery", "year": "2007", "unstructured": "Slattery ML, Curtin K, Sweeney C et al (2007) Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 120:656\u2013663", "journal-title": "Int J Cancer"}, {"key": "9659_CR12", "doi-asserted-by": "crossref", "first-page": "2114", "DOI": "10.1093/jn/137.9.2114", "volume": "137", "author": "M Donk van den", "year": "2007", "unstructured": "van den Donk M, Pellis L, Crott JW et al (2007) Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas. J Nutr 137:2114\u20132120", "journal-title": "J Nutr"}, {"key": "9659_CR13", "first-page": "5860", "volume": "9", "author": "K Kawakami", "year": "2003", "unstructured": "Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Watanabe G, Iacopetta B (2003) The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 9:5860\u20135865", "journal-title": "Clin Cancer Res"}, {"key": "9659_CR14", "doi-asserted-by": "crossref", "first-page": "1765", "DOI": "10.1093/carcin/bgn074", "volume": "29", "author": "S Vogel de", "year": "2008", "unstructured": "de Vogel S, Bongaerts BW, Wouters KA et al (2008) Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. Carcinogenesis 29:1765\u20131773", "journal-title": "Carcinogenesis"}, {"key": "9659_CR15", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1038/ng0595-111", "volume": "10", "author": "P Frosst", "year": "1995", "unstructured": "Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111\u2013113", "journal-title": "Nat Genet"}, {"key": "9659_CR16", "doi-asserted-by": "crossref", "first-page": "1044", "DOI": "10.1086/301825", "volume": "62", "author": "NM Put van der", "year": "1998", "unstructured": "van der Put NM, Gabreels F, Stevens EM et al (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044\u20131051", "journal-title": "Am J Hum Genet"}, {"key": "9659_CR17", "doi-asserted-by": "crossref", "first-page": "1672", "DOI": "10.1093/carcin/bgm089", "volume": "28", "author": "K Curtin", "year": "2007", "unstructured": "Curtin K, Slattery ML, Ulrich CM et al (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28:1672\u20131679", "journal-title": "Carcinogenesis"}, {"key": "9659_CR18", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1007/s10552-009-9464-2", "volume": "21", "author": "A Hazra", "year": "2010", "unstructured": "Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S (2010) Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control 21:331\u2013345", "journal-title": "Cancer Causes Control"}, {"key": "9659_CR19", "first-page": "649", "volume": "24", "author": "K Oyama", "year": "2004", "unstructured": "Oyama K, Kawakami K, Maeda K, Ishiguro K, Watanabe G (2004) The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Anticancer Res 24:649\u2013654", "journal-title": "Anticancer Res"}, {"key": "9659_CR20", "unstructured": "de Vogel S, Wouters KA, Gottschalk RW et al. (2009) Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev (in press)", "DOI": "10.1158/1055-9965.EPI-09-0289", "doi-asserted-by": "crossref"}, {"key": "9659_CR21", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1016/0895-4356(90)90009-E", "volume": "43", "author": "PA Brandt van den", "year": "1990", "unstructured": "van den Brandt PA, Goldbohm RA, van \u2018t Veer P, Volovics A, Hermus RJ, Sturmans F (1990) A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 43:285\u2013295", "journal-title": "J Clin Epidemiol"}, {"key": "9659_CR22", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1093/ije/19.3.553", "volume": "19", "author": "PA Brandt Van den", "year": "1990", "unstructured": "Van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, Hunen PM (1990) Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 19:553\u2013558", "journal-title": "Int J Epidemiol"}, {"key": "9659_CR23", "first-page": "19", "volume": "29", "author": "M Casparie", "year": "2007", "unstructured": "Casparie M, Tiebosch AT, Burger G et al (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29:19\u201324", "journal-title": "Cell Oncol"}, {"key": "9659_CR24", "unstructured": "Nevo Table (1986) Dutch food composition table\u00a01986\u20131987, Voorlichtingsbureau voor de voeding, The Hague, The Netherlands, 1986"}, {"key": "9659_CR25", "first-page": "253", "volume": "48", "author": "RA Goldbohm", "year": "1994", "unstructured": "Goldbohm RA, van den Brandt PA, Brants HA et al (1994) Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 48:253\u2013265", "journal-title": "Eur J Clin Nutr"}, {"key": "9659_CR26", "first-page": "420", "volume": "49", "author": "RA Goldbohm", "year": "1995", "unstructured": "Goldbohm RA, van \u2018t Veer P, van den Brandt PA et al (1995) Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 49:420\u2013429", "journal-title": "Eur J Clin Nutr"}, {"key": "9659_CR27", "first-page": "119", "volume": "82", "author": "EJ Konings", "year": "1999", "unstructured": "Konings EJ (1999) A validated liquid chromatographic method for determining folates in vegetables, milk powder, liver, and flour. J AOAC Int 82:119\u2013127", "journal-title": "J AOAC Int"}, {"key": "9659_CR28", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1093/ajcn/73.4.765", "volume": "73", "author": "EJ Konings", "year": "2001", "unstructured": "Konings EJ, Roomans HH, Dorant E, Goldbohm RA, Saris WH, van den Brandt PA (2001) Folate intake of the Dutch population according to newly established liquid chromatography data for foods. Am J Clin Nutr 73:765\u2013776", "journal-title": "Am J Clin Nutr"}, {"key": "9659_CR29", "doi-asserted-by": "crossref", "first-page": "1664", "DOI": "10.1373/clinchem.2004.034058", "volume": "50", "author": "AM Knaapen", "year": "2004", "unstructured": "Knaapen AM, Ketelslegers HB, Gottschalk RW et al (2004) Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension. Clin Chem 50:1664\u20131668", "journal-title": "Clin Chem"}, {"key": "9659_CR30", "doi-asserted-by": "crossref", "first-page": "9821", "DOI": "10.1073/pnas.93.18.9821", "volume": "93", "author": "JG Herman", "year": "1996", "unstructured": "Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821\u20139826", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9659_CR31", "doi-asserted-by": "crossref", "first-page": "1804", "DOI": "10.1053/gast.2002.37070", "volume": "123", "author": "N Suraweera", "year": "2002", "unstructured": "Suraweera N, Duval A, Reperant M et al (2002) Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123:1804\u20131811", "journal-title": "Gastroenterology"}, {"key": "9659_CR32", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.1080/01621459.1989.10478874", "volume": "84", "author": "D Lin", "year": "1989", "unstructured": "Lin D, Wei L (1989) The robust inference for the Cox Proportional Hazards Model. JASA 84:1074\u20131078", "journal-title": "JASA"}, {"key": "9659_CR33", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1093/biomet/69.1.239", "volume": "69", "author": "D Schoenfeld", "year": "1982", "unstructured": "Schoenfeld D (1982) Partial residuals for the proportional hazards regression models. Biometrika 69:239\u2013241", "journal-title": "Biometrika"}, {"key": "9659_CR34", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1093/oxfordjournals.aje.a114366", "volume": "124", "author": "W Willett", "year": "1986", "unstructured": "Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17\u201327", "journal-title": "Am J Epidemiol"}, {"key": "9659_CR35", "doi-asserted-by": "crossref", "first-page": "5606", "DOI": "10.1073/pnas.062066299", "volume": "99", "author": "S Friso", "year": "2002", "unstructured": "Friso S, Choi SW, Girelli D et al (2002) A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606\u20135611", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9659_CR36", "first-page": "849", "volume": "9", "author": "LL Stern", "year": "2000", "unstructured": "Stern LL, Mason JB, Selhub J, Choi SW (2000) Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 9:849\u2013853", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9659_CR37", "doi-asserted-by": "crossref", "first-page": "3662", "DOI": "10.3748/wjg.14.3662", "volume": "14", "author": "P Mokarram", "year": "2008", "unstructured": "Mokarram P, Naghibalhossaini F, Saberi Firoozi M et al (2008) Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B(12) status. World J Gastroenterol 14:3662\u20133671", "journal-title": "World J Gastroenterol"}, {"key": "9659_CR38", "doi-asserted-by": "crossref", "first-page": "2136", "DOI": "10.1158/1055-9965.EPI-07-2895", "volume": "17", "author": "JC Figueiredo", "year": "2008", "unstructured": "Figueiredo JC, Levine AJ, Grau MV et al (2008) Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev 17:2136\u20132145", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9659_CR39", "doi-asserted-by": "crossref", "first-page": "3086", "DOI": "10.1158/1055-9965.EPI-09-0289", "volume": "18", "author": "S Vogel de", "year": "2009", "unstructured": "de Vogel S, Wouters KA, Gottschalk RW et al (2009) Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev 18:3086\u20133096", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9659_CR40", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1002/mnfr.200600191", "volume": "51", "author": "YI Kim", "year": "2007", "unstructured": "Kim YI (2007) Folate and colorectal cancer: An evidence-based critical review. Mol Nutr Food Res 51:267\u2013292", "journal-title": "Mol Nutr Food Res"}, {"key": "9659_CR41", "doi-asserted-by": "crossref", "first-page": "2767", "DOI": "10.1002/ijc.23470", "volume": "122", "author": "S Ogino", "year": "2008", "unstructured": "Ogino S, Kawasaki T, Nosho K et al (2008) LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 122:2767\u20132773", "journal-title": "Int J Cancer"}, {"key": "9659_CR42", "first-page": "4992", "volume": "62", "author": "H Shen", "year": "2002", "unstructured": "Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q (2002) A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 62:4992\u20134995", "journal-title": "Cancer Res"}, {"key": "9659_CR43", "doi-asserted-by": "crossref", "first-page": "3663", "DOI": "10.1158/1078-0432.CCR-08-2383", "volume": "15", "author": "K Nosho", "year": "2009", "unstructured": "Nosho K, Shima K, Irahara N et al (2009) DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 15:3663\u20133671", "journal-title": "Clin Cancer Res"}, {"key": "9659_CR44", "first-page": "569", "volume": "14", "author": "R Singal", "year": "2005", "unstructured": "Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ (2005) Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. Oncol Rep 14:569\u2013573", "journal-title": "Oncol Rep"}, {"key": "9659_CR45", "first-page": "993", "volume": "25", "author": "L Wang", "year": "2004", "unstructured": "Wang L, Rodriguez M, Kim ES et al (2004) A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int J Oncol 25:993\u2013999", "journal-title": "Int J Oncol"}, {"key": "9659_CR46", "doi-asserted-by": "crossref", "first-page": "3110", "DOI": "10.1101/gad.1594007", "volume": "21", "author": "HG Linhart", "year": "2007", "unstructured": "Linhart HG, Lin H, Yamada Y et al (2007) Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21:3110\u20133122", "journal-title": "Genes Dev"}, {"key": "9659_CR47", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1158/1055-9965.EPI-07-2608", "volume": "17", "author": "AY Jung", "year": "2008", "unstructured": "Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM (2008) DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 17:330\u2013338", "journal-title": "Cancer Epidemiol Biomarkers Prev"}], "container-title": ["Cancer Causes & Control"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10552-010-9659-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 5]], "date-time": "2019-06-05T16:10:56Z", "timestamp": 1559751056000}, "score": 31.048128, "issued": {"date-parts": [[2010, 10, 20]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "1"}, "alternative-id": ["9659"], "URL": "http://dx.doi.org/10.1007/s10552-010-9659-6", "relation": {"cites": []}, "ISSN": ["0957-5243", "1573-7225"], "issn-type": [{"value": "0957-5243", "type": "print"}, {"value": "1573-7225", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:21:59Z", "timestamp": 1574364119667}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2008, 4, 15]]}, "DOI": "10.1158/0008-5472.can-07-6405", "type": "journal-article", "created": {"date-parts": [[2008, 4, 15]], "date-time": "2008-04-15T18:14:04Z", "timestamp": 1208283244000}, "page": "2570-2575", "source": "Crossref", "is-referenced-by-count": 36, "title": ["A Requirement for DICER to Maintain Full Promoter CpG Island Hypermethylation in Human Cancer Cells"], "prefix": "10.1158", "volume": "68", "author": [{"given": "A. H.", "family": "Ting", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Suzuki", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Cope", "sequence": "additional", "affiliation": []}, {"given": "K. E.", "family": "Schuebel", "sequence": "additional", "affiliation": []}, {"given": "B. H.", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Toyota", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Imai", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Shinomura", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Tokino", "sequence": "additional", "affiliation": []}, {"given": "S. B.", "family": "Baylin", "sequence": "additional", "affiliation": []}], "member": "1086", "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-07-6405", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T09:40:34Z", "timestamp": 1482486034000}, "score": 30.884043, "issued": {"date-parts": [[2008, 4, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 4, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-07-6405", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:47:04Z", "timestamp": 1574124424244}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 4, 1]], "date-time": "1994-04-01T00:00:00Z", "timestamp": 765158400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[1994, 4]]}, "DOI": "10.1016/0270-9139(94)90386-7", "type": "journal-article", "created": {"date-parts": [[2004, 4, 30]], "date-time": "2004-04-30T10:03:32Z", "timestamp": 1083319412000}, "page": "I54", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Phase II study of intraarterial chemotherapy (IAC) in metastatic colorectal carcinoma (CRC) to the liver"], "prefix": "10.1016", "volume": "19", "author": [{"given": "A", "family": "Cyjon", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0270-9139(94)90386-7?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0270-9139(94)90386-7?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T22:25:50Z", "timestamp": 1549751150000}, "score": 30.82621, "issued": {"date-parts": [[1994, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 4]]}, "issue": "4"}, "alternative-id": ["0270-9139(94)90386-7"], "URL": "http://dx.doi.org/10.1016/0270-9139(94)90386-7", "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:05:00Z", "timestamp": 1574503500754}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "21", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2012, 11, 1]]}, "DOI": "10.1158/1078-0432.ccr-11-3252", "type": "journal-article", "created": {"date-parts": [[2012, 9, 15]], "date-time": "2012-09-15T02:08:48Z", "timestamp": 1347674928000}, "page": "6023-6031", "source": "Crossref", "is-referenced-by-count": 43, "title": ["Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer"], "prefix": "10.1158", "volume": "18", "author": [{"given": "P. A.", "family": "Tang", "sequence": "first", "affiliation": []}, {"given": "S. J.", "family": "Cohen", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Kollmannsberger", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Bjarnason", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Virik", "sequence": "additional", "affiliation": []}, {"given": "M. J.", "family": "MacKenzie", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Lourenco", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "M. J.", "family": "Moore", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2012, 9, 13]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-11-3252", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:57:59Z", "timestamp": 1482469079000}, "score": 30.811794, "issued": {"date-parts": [[2012, 9, 13]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 11, 6]]}, "published-print": {"date-parts": [[2012, 11, 1]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-11-3252", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T15:26:13Z", "timestamp": 1574263573179}, "reference-count": 23, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 11, 1]], "date-time": "2008-11-01T00:00:00Z", "timestamp": 1225497600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Colorectal Cancer"], "published-print": {"date-parts": [[2008, 11]]}, "DOI": "10.3816/ccc.2008.n.052", "type": "journal-article", "created": {"date-parts": [[2008, 11, 27]], "date-time": "2008-11-27T02:07:03Z", "timestamp": 1227751623000}, "page": "390-397", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer"], "prefix": "10.3816", "volume": "7", "author": [{"given": "Thomas", "family": "Cartwright", "sequence": "first", "affiliation": []}, {"given": "Paul", "family": "Kuefler", "sequence": "additional", "affiliation": []}, {"given": "Allen", "family": "Cohn", "sequence": "additional", "affiliation": []}, {"given": "William", "family": "Hyman", "sequence": "additional", "affiliation": []}, {"given": "Maury", "family": "Berger", "sequence": "additional", "affiliation": []}, {"given": "Donald", "family": "Richards", "sequence": "additional", "affiliation": []}, {"given": "Svetislava", "family": "Vukelja", "sequence": "additional", "affiliation": []}, {"given": "John E.", "family": "Nugent", "sequence": "additional", "affiliation": []}, {"suffix": "Jr", "given": "Robert L.", "family": "Ruxer", "sequence": "additional", "affiliation": []}, {"given": "Kristi A.", "family": "Boehm", "sequence": "additional", "affiliation": []}, {"given": "Lina", "family": "Asmar", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Colorectal Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1533002811704480?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1533002811704480?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 24]], "date-time": "2018-12-24T04:23:45Z", "timestamp": 1545625425000}, "score": 30.782085, "issued": {"date-parts": [[2008, 11]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2008, 11]]}, "issue": "6"}, "alternative-id": ["S1533002811704480"], "URL": "http://dx.doi.org/10.3816/ccc.2008.n.052", "ISSN": ["1533-0028"], "issn-type": [{"value": "1533-0028", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}